- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mega Lifesciences PCL (MEGA)
Mega Lifesciences PCL stock price, this page displays BK MEGA stock exchange data. View the MEGA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Mega Lifesciences PCL real time stock price chart below.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEGA quote. (ISIN: TH4984010009)
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEGA quote. (ISIN: TH4984010009)
33.50
-2.25(-6.29%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
33.00
34.25
52 wk Range
24.30
40.00
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
33.0034.25
52 wk Range
24.3040.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.48%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.48%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MEGA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
39.64
Upside
+18.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, including medical and sports nutrition, general well-being, vitamins, probiotics, herbal medicines, and cough and cold medicines, as well as hair, kid’s, men’s, and women’s care products; and various health concerns products, such as allergy, bone and joint, gut, liver, diabetic, eye, heart, brain, sleep and anxiety, pain, and skin care, as well as blood circulation and memory. The company also provides prescription medicines for anti-allergic, anti-infective, cardiovascular system, central nervous system, dermatology, diabetes, gastrointestinal, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology areas under the MEGA We care brand name. In addition, it offers logistical and marketing services for trading and sale of goods manufactured by third parties comprising warehouse management, collections, and value-added services; natural and plant-based health foods; digital support solutions; and operation of wellness center. Further, the company is involved in social enterprise; and software design, development, and other services. It sells its products in in Southeast Asia, Sub-Saharan Africa, Australia, Europe, and South America. Mega Lifesciences Public Company Limited was incorporated in 1982 and is headquartered in Bangkok, Thailand.
Mega Lifesciences PCL Earnings Call Summary for Q3/2025
- Mega Lifesciences reported Q3 2025 revenue of 3.88B THB with EPS of 0.57 THB, meeting market expectations and driving a 2.52% stock price increase to 30.5 THB.
- The company's branded business grew 4.3% YoY while overall revenue decline narrowed to 10.3%; gross profit margin improved to 51.8% from 49.6% in 2024.
- Net profits reached 1,335M THB (flat YoY) with strong operating cash flows of 1.7B THB (128% of profits), demonstrating operational efficiency.
- Management projects 2025 adjusted net profits of 1,950M THB with a dividend payout of 50-60% and aims to double the branded business within five years.
- CEO Vivek Dhawan highlighted the company's balanced portfolio across 33 markets, with 50-60% in consumer health products and 40-50% in pharmaceuticals.
Last Updated: 24-11-2025, 10:34 pm
Read Full TranscriptCompare MEGA to Peers and Sector
Metrics to compare | MEGA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEGAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.3x | 22.2x | −0.5x | |
PEG Ratio | −3.26 | 0.47 | 0.00 | |
Price/Book | 3.1x | 2.9x | 2.6x | |
Price / LTM Sales | 2.2x | 3.7x | 3.2x | |
Upside (Analyst Target) | 10.5% | 15.0% | 51.2% | |
Fair Value Upside | Unlock | 12.2% | 7.3% | Unlock |
Analyst Ratings
3 Buy
3 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 39.64
(+18.34% Upside)
Earnings
Latest Release
Feb 24, 2026
EPS / Forecast
0.66 / 0.66
Revenue / Forecast
3.66B / --
FAQ
What Is the Mega Lifesciences (MEGA) Stock Price Today?
The Mega Lifesciences stock price today is 33.50.
What Stock Exchange Does Mega Lifesciences Trade On?
Mega Lifesciences is listed and trades on the Thailand Stock Exchange.
What Is the Stock Symbol for Mega Lifesciences?
The stock symbol for Mega Lifesciences is "MEGA."
Does Mega Lifesciences Pay Dividends? What’s The Current Dividend Yield?
The Mega Lifesciences dividend yield is 4.48%.
What Is the Mega Lifesciences Market Cap?
As of today, Mega Lifesciences market cap is 29.21B.
What Is Mega Lifesciences's Earnings Per Share (TTM)?
The Mega Lifesciences EPS (TTM) is 2.19.
When Is the Next Mega Lifesciences Earnings Date?
Mega Lifesciences will release its next earnings report on 08-05-2026.
From a Technical Analysis Perspective, Is MEGA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Mega Lifesciences Stock Split?
Mega Lifesciences has split 0 times.
How Many Employees Does Mega Lifesciences Have?
Mega Lifesciences has 900 employees.
What is the current trading status of Mega Lifesciences (MEGA)?
As of 09-03-2026, Mega Lifesciences (MEGA) is trading at a price of 33.50, with a previous close of 35.75. The stock has fluctuated within a day range of 33.00 to 34.25, while its 52-week range spans from 24.30 to 40.00.
What Is Mega Lifesciences (MEGA) Price Target According to Analysts?
The average 12-month price target for Mega Lifesciences is THB39.64, with a high estimate of THB45 and a low estimate of THB33. 3 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +18.34% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.